Northern Trust Corp Lucid Diagnostics Inc. Transaction History
Northern Trust Corp
- $709 Billion
- Q2 2025
A detailed history of Northern Trust Corp transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 529,419 shares of LUCD stock, worth $529,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
529,419
Previous 41,780
1167.16%
Holding current value
$529,419
Previous $62,000
880.65%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LUCD
# of Institutions
69Shares Held
15.2MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.13MShares$4.13 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA2.73MShares$2.73 Million0.21% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL1.89MShares$1.89 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.58MShares$1.58 Million0.0% of portfolio
-
Luminus Management LLC Houston, TX457KShares$456,6440.62% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $38.6M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...